Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation (NCT07072767)
Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication
🩺 Plain-English Summary (8th-Grade Level)
The study is a 2-arm randomized controlled trial among patients referred for kidney transplant evaluation at a single transplant center to compare the effects of a digital-analog intervention to increase living-donor kidney transplant access (KidneyTIME+) with or without human guide . Following consent and baseline assessment, participants are randomized, stratified by self-reported race, with equal allocation to 2 treatment arms: the KidneyTIME+ intervention with or without human guide.
Who can join: Review the eligibility criteria below.
Location: Erie County Medical Center, 462 Grider Street — Buffalo, New York
Age range: 18 Years
🧪 Interventions in This Study
- Digital education outreach intervention for kidney transplant access and human guide (BEHAVIORAL)
- Digital education outreach intervention for kidney transplant access only (unguided) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Erie County Medical Center, 462 Grider Street — Buffalo, New York
📞 Contact the Study Coordinator
Phone: (716) 898-3318
Email: lkayler@ecmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in End-Stage Renal Disease
Explore by condition: All End-Stage Renal Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.